Comorbidity, age and overall survival in patients with advanced pancreatic cancer – Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo
Titel:
Comorbidity, age and overall survival in patients with advanced pancreatic cancer – Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo
Auteur:
Vickers, M.M. Powell, E.D. Asmis, T.R. Jonker, D.J. Hilton, J.F. O’Callaghan, C.J. Tu, D. Parulekar, W. Moore, M.J.